Urszula N. Wasko

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Andrea Califano · 3 shared papers, 2024–2026 · strength 0.58
   • Paper Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic … DOI 10.1038/s41588-026-02714-8↗
   • Paper Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Cl… DOI 10.1200/po-26-00138↗
   • Paper Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. DOI 10.1158/2159-8290.cd-23-0240↗
2. Kenneth P. Olive · 3 shared papers, 2024–2026 · strength 0.58
   • Paper Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic … DOI 10.1038/s41588-026-02714-8↗
   • Paper Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Cl… DOI 10.1200/po-26-00138↗
   • Paper Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. DOI 10.1158/2159-8290.cd-23-0240↗
3. Alina Cornelia Iuga · 2 shared papers, 2026 · strength 0.41
   • Paper Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic … DOI 10.1038/s41588-026-02714-8↗
   • Paper Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Cl… DOI 10.1200/po-26-00138↗
4. Gulam Abbas Manji · 2 shared papers, 2026 · strength 0.41
   • Paper Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic … DOI 10.1038/s41588-026-02714-8↗
   • Paper Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Cl… DOI 10.1200/po-26-00138↗
5. Álvaro Curiel‐García · 2 shared papers, 2024–2026 · strength 0.38
   • Paper Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic … DOI 10.1038/s41588-026-02714-8↗
   • Paper Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. DOI 10.1158/2159-8290.cd-23-0240↗
6. H. Carlo Maurer · 2 shared papers, 2024–2026 · strength 0.38
   • Paper Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic … DOI 10.1038/s41588-026-02714-8↗
   • Paper Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. DOI 10.1158/2159-8290.cd-23-0240↗
7. Ela Elyada · 1 shared paper, 2026 · strength 0.21
   • Paper Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic … DOI 10.1038/s41588-026-02714-8↗
8. Sabrina Ge · 1 shared paper, 2026 · strength 0.21
   • Paper Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic … DOI 10.1038/s41588-026-02714-8↗
9. Pasquale Laise · 1 shared paper, 2026 · strength 0.21
   • Paper Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic … DOI 10.1038/s41588-026-02714-8↗
10. Faiyaz Notta · 1 shared paper, 2026 · strength 0.21
    • Paper Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic … DOI 10.1038/s41588-026-02714-8↗
11. David Arthur Tuveson · 1 shared paper, 2026 · strength 0.21
    • Paper Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic … DOI 10.1038/s41588-026-02714-8↗
12. Michael S. May · 1 shared paper, 2026 · strength 0.20
    • Paper Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Cl… DOI 10.1200/po-26-00138↗
13. Alexander Grenander Raufi · 1 shared paper, 2026 · strength 0.20
    • Paper Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Cl… DOI 10.1200/po-26-00138↗
14. Susan Elaine Bates · 1 shared paper, 2026 · strength 0.20
    • Paper Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Cl… DOI 10.1200/po-26-00138↗
15. Emanuel F. Petricoin · 1 shared paper, 2026 · strength 0.20
    • Paper Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Cl… DOI 10.1200/po-26-00138↗
16. Brian William Labadie · 1 shared paper, 2026 · strength 0.20
    • Paper Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Cl… DOI 10.1200/po-26-00138↗
17. Linda Y. Wu · 1 shared paper, 2026 · strength 0.20
    • Paper Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Cl… DOI 10.1200/po-26-00138↗
18. Benjamin Izar · 1 shared paper, 2026 · strength 0.20
    • Paper Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Cl… DOI 10.1200/po-26-00138↗
19. Howard P. Safran · 1 shared paper, 2026 · strength 0.20
    • Paper Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Cl… DOI 10.1200/po-26-00138↗
20. Alexander Starodub · 1 shared paper, 2026 · strength 0.18
    • Paper Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategie… DOI 10.1038/s41591-026-04537-w↗
21. Ashenafi Shiferaw Bulle · 1 shared paper, 2026 · strength 0.18
    • Paper Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategie… DOI 10.1038/s41591-026-04537-w↗
22. Julien Dilly · 1 shared paper, 2026 · strength 0.18
    • Paper Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategie… DOI 10.1038/s41591-026-04537-w↗
23. Wungki Park · 1 shared paper, 2026 · strength 0.18
    • Paper Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategie… DOI 10.1038/s41591-026-04537-w↗
24. Ida Aronchik · 1 shared paper, 2026 · strength 0.18
    • Paper Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategie… DOI 10.1038/s41591-026-04537-w↗
25. Andrew J. Aguirre · 1 shared paper, 2026 · strength 0.18
    • Paper Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategie… DOI 10.1038/s41591-026-04537-w↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.